Publicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (15)

2024

  1. Predictors of unsustained measurable residual disease negativity in transplant-eligible patients with multiple myeloma

    Blood, Vol. 143, Núm. 7, pp. 597-603

2023

  1. Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal Gammopathies

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 16, pp. 3019-3031

2022

  1. A Machine Learning Model Based on Tumor and Immune Biomarkers to Predict Undetectable MRD and Survival Outcomes in Multiple Myeloma

    Clinical cancer research : an official journal of the American Association for Cancer Research

  2. Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 40, Núm. 27, pp. 3151-3161

2021

  1. Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- And high-risk myeloma

    Blood, Vol. 137, Núm. 1, pp. 49-60

2020

  1. Measurable Residual Disease by Next-Generation Flow Cytometry in Multiple Myeloma

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 38, Núm. 8, pp. 784-792

2019

  1. Bortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplant in multiple myeloma

    Blood, Vol. 134, Núm. 16, pp. 1337-1345

2017

  1. Identification of underlying and transfusion-related platelet qualitative alterations in the hemato-oncologic patient

    Transfusion and Apheresis Science, Vol. 56, Núm. 5, pp. 756-768

  2. Therapy-related myeloid neoplasms as a concerning complication in acute promyelocytic leukemia

    Hematology Reports, Vol. 9, Núm. 3, pp. 114-117

2014

  1. Comparación de guías internacionales sobre púrpura trombocitopénica autoinmunitaria primaria

    Medicina Clinica, Vol. 143, Núm. 9, pp. 408-419

1996

  1. Tratamiento de la leucemia aguda en el paciente de edad avanzada

    Medicina Clinica

1994

  1. Acquired hemoglobin H disease associated with a myelodysplastic syndrome

    Sangre, Vol. 39, Núm. 3, pp. 211-213

1993

  1. TRATAMIENTO DE LA LEUCEMIA LINFOBLASTICA AGUDA DEL ADULTO

    Revisiones en Cancer

1989

  1. Complete remision of acute promyelocytic leukemia without bone marrow aplasia in a patient treated with aggressive chemotherapy

    Anales de Medicina Interna, Vol. 6, Núm. 5, pp. 255-256

1986

  1. BACTERIEMIA PERSISTENTE POR CORYNEBACTERIUM SP POLIRRESISTENTE EN UN PACIENTE LEUCEMICO

    Medicina Clinica, Vol. 86, Núm. 17, pp. 719-720